CUSIP: 00507W107
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,737,744
-
Share change
-
-505,216
-
Total reported value
-
$5,021,000
-
Price per share
-
$0.87
-
Number of holders
-
30
-
Value change
-
-$452,184
-
Number of buys
-
11
-
Number of sells
-
10
Quarterly Holders Quick Answers
What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q4 2016
As of 31 Dec 2016,
ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,737,744 shares.
The largest 10 holders included
Sio Capital Management, LLC, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, D.A. DAVIDSON & CO., BlackRock Fund Advisors, and NORTHERN TRUST CORP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.